Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
About the team: The study is by researchers Alan S. Perelson from Los Alamos National Laboratory, Susan L. Uprichard and Natasha Sansone from University of Illinois at Chicago; Harel Dahari, Thomas Layden and Scott J. Cotler from Loyola University, Chicago; Richard Nettles from Bristol-Myers Squibb and Jeremie Guedj from Institut National de la Santé et de la Recherche Médicale, France.
The research was funded by National Institutes of Health, the National Science Foundation and the University of Illinois Walter Payton Liver Center Guild.
Link to paper online: “Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life.” http://www.pnas.org/content/early/2013/02/13/1203110110.abstract
DOE/Los Alamos National Laboratory
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Liver Disease / Hepatitis category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
DOE/Los Alamos National Laboratory. "How Surprisingly Potent Hepatitis C Drug Works Revealed By Computer Modeling." Medical News Today. MediLexicon, Intl., 22 Feb. 2013. Web.
8 Mar. 2014. <http://www.medicalnewstoday.com/releases/256657>
DOE/Los Alamos National Laboratory. (2013, February 22). "How Surprisingly Potent Hepatitis C Drug Works Revealed By Computer Modeling." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/256657.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.